Pacific Biosciences of California
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $39,224 | $39,967 | $36,013 | $38,810 |
Gross Profit | 10,058 | 10,004 | 5,938 | 4,429 |
EBITDA | -122,662 | -41,088 | -155,488 | -62,589 |
EBIT | -133,611 | -57,187 | -169,777 | -74,603 |
Net Income | 2,371 | -60,725 | -173,319 | -78,178 |
Net Change In Cash | 39,224 | 39,967 | 36,013 | 38,810 |
Free Cash Flow | -32,267 | -44,676 | -55,742 | -79,561 |
Cash | 55,370 | 77,982 | 99,526 | 76,946 |
Basic Shares | 306,892 | 272,915 | 272,385 | 269,578 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $154,014 | $200,521 | $128,304 | $130,513 |
Gross Profit | 37,282 | 52,780 | 49,035 | 58,860 |
EBITDA | -356,381 | -277,282 | -282,240 | -250,757 |
EBIT | -409,732 | -303,816 | -299,558 | -262,342 |
Net Income | -309,851 | -306,735 | -296,930 | -181,223 |
Net Change In Cash | 154,014 | 200,521 | 128,304 | 130,513 |
Cost of Revenue | 379,870 | |||
Free Cash Flow | -212,246 | -268,016 | -280,140 | -117,111 |
Cash | 55,370 | 179,911 | 325,089 | 460,725 |
Basic Shares | 288,366 | 253,629 | 224,550 | 204,136 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.20 |
2024-09-30 | -$0.22 |
2024-06-30 | -$0.64 |
2024-03-31 | -$0.29 |
